Market revenue in 2022 | USD 198.7 million |
Market revenue in 2030 | USD 270.2 million |
Growth rate | 3.9% (CAGR from 2022 to 2030) |
Largest segment | Antibiotics |
Fastest growing segment | Antimicrobial |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antimicrobial, Antibiotics |
Key market players worldwide | Boehringer Ingelheim, CEVA Inc, Elanco Animal Health Inc, Neogen Corp, Phibro Animal Health Corp Class A, Vetoquinol SA, Virbac SA, Zoetis Inc Class A |
Antibiotics was the largest segment with a revenue share of 50.18% in 2022. Horizon Databook has segmented the Asia Pacific animal antimicrobial and antibiotics market based on antimicrobial, antibiotics covering the revenue growth of each sub-segment from 2018 to 2030.
Asia is the largest meat producer accounting for around 40-45% of the world’s total meat production. According to React report, India is the world’s 5th largest producer of meat. Chicken is the most consumed meat in India.
Increase in usage of antimicrobial and antibiotics in chicken is expected to drive the market growth in the region. Additionally, Asia Pacific region is home to a large population of livestock, including cattle, swine, poultry, and aquaculture, which provides ample opportunities for the animal antimicrobial and antibiotics market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account